0000899243-22-029030.txt : 20220817
0000899243-22-029030.hdr.sgml : 20220817
20220817173929
ACCESSION NUMBER: 0000899243-22-029030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220815
FILED AS OF DATE: 20220817
DATE AS OF CHANGE: 20220817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arbuckle Stuart A
CENTRAL INDEX KEY: 0001557290
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 221175522
MAIL ADDRESS:
STREET 1: VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-15
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001557290
Arbuckle Stuart A
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, COO
Common Stock
2022-08-15
4
M
0
6571
155.57
A
67451
D
Common Stock
2022-08-15
4
S
0
1254
300.30
D
66197
D
Common Stock
2022-08-15
4
S
0
4242
301.61
D
61955
D
Common Stock
2022-08-15
4
S
0
400
302.55
D
61555
D
Common Stock
2022-08-15
4
S
0
2339
303.78
D
59216
D
Common Stock
2022-08-15
4
S
0
6990
304.67
D
52226
D
Common Stock
2022-08-15
4
S
0
6948
305.38
D
45278
D
Common Stock
140
I
401(k)
Stock Option (Right to Buy)
155.57
2022-08-15
4
M
0
6571
0.00
D
2028-02-05
Common Stock
6571
0
D
Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $300.30 (range $300.00 to $300.73).
Open market sales reported on this line occurred at a weighted average price of $301.61 (range $301.09 to $302.01).
Open market sales reported on this line occurred at a weighted average price of $302.55 (range $302.13 to $302.90).
Open market sales reported on this line occurred at a weighted average price of $303.78 (range $303.13 to $304.09).
Open market sales reported on this line occurred at a weighted average price of $304.67 (range $304.13 to $305.12).
Open market sales reported on this line occurred at a weighted average price of $305.38 (range $305.13 to $305.83).
Fully vested.
/s/ Joy Liu, Attorney-in-Fact
2022-08-17